Expert review document part 2: methodology, terminology and clinical applications of optical coherence tomography for the assessment of interventional procedures

This document is complementary to an Expert Review Document on Optical Coherence Tomography (OCT) for the study of coronary arteries and atherosclerosis.1 The goal of this companion manuscript is to provide a practical guide framework for the appropriate use and reporting of the novel frequency domain (FD) OCT imaging to guide interventional procedures, with a particular interest on the comparison with intravascular ultrasound (IVUS).1–4 In the OCT Expert Review Document on Atherosclerosis, a comprehensive description of the physical principles for OCT imaging and time domain (TD) catheters (St Jude Medical, Westford, MA, USA) was provided.1 The main advantage of FD-OCT is that the technology enables rapid imaging of the coronary artery, using a non-occlusive acquisition modality. The FD-OCT catheter (DragonflyTM; St Jude Medical) employs a single-mode optical fibre, enclosed in a hollow metal torque wire that rotates at a speed of 100 r.p.s. It is compatible with a conventional 0.014″ angioplasty guide wire, inserted into a short monorail lumen at the tip. The frequency domain optical coherence tomography lateral resolution is improved in comparison with TD-OCT, while the axial resolution did not change. These features, together with reduced motion artefacts and an increased maximum field of view up to 11 mm, have significantly improved both the quality and ease of use of OCT in the catheterization laboratory.3,4 However, the imaging depth of the FD-OCT is still limited to 0.5–2.0 mm.5 The main obstacle to the adoption of TD-OCT imaging in clinical practice is that OCT cannot image through a blood field, and therefore requires clearing or flushing of blood from the lumen.1 The 6 Fr compatible DragonflyTM FD-OCT catheter is so far the only one in the market, as two other systems from Volcano and Terumo, which …

[1]  T. Kume,et al.  Optical coherence tomography evaluation of zotarolimus-eluting stents at 9-month follow-up: comparison with sirolimus-eluting stents , 2009, Heart.

[2]  Young-Hak Kim,et al.  Impact of Intravascular Ultrasound Guidance on Long-Term Mortality in Stenting for Unprotected Left Main Coronary Artery Stenosis , 2009, Circulation. Cardiovascular interventions.

[3]  Ruslan Hlushchuk,et al.  Coronary optical frequency domain imaging (OFDI) for in vivo evaluation of stent healing: comparison with light and electron microscopy , 2010, European heart journal.

[4]  Giuseppe Biondi-Zoccai,et al.  Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents. , 2010, JACC. Cardiovascular interventions.

[5]  Eiji Toyota,et al.  Assessment of coronary arterial plaque by optical coherence tomography. , 2006, The American journal of cardiology.

[6]  Benjamin J Vakoc,et al.  Three-dimensional coronary artery microscopy by intracoronary optical frequency domain imaging. , 2008, JACC. Cardiovascular imaging.

[7]  F. Prati,et al.  Local delivery versus intracoronary infusion of abciximab in patients with acute coronary syndromes. , 2010, JACC. Cardiovascular interventions.

[8]  Hiromasa Otake,et al.  Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography. , 2007, European heart journal.

[9]  P. Fitzgerald,et al.  Impact of late incomplete stent apposition after sirolimus-eluting stent implantation on 4-year clinical events: intravascular ultrasound analysis from the multicentre, randomised, RAVEL, E-SIRIUS and SIRIUS trials , 2007, Heart.

[10]  F. Prati,et al.  Safety and feasibility of frequency domain optical coherence tomography to guide decision making in percutaneous coronary intervention. , 2010, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[11]  C. Di Mario,et al.  Randomized Comparison of Coronary Stent Implantation Under Ultrasound or Angiographic Guidance to Reduce Stent Restenosis (OPTICUS Study) , 2001, Circulation.

[12]  Giuseppe Biondi-Zoccai,et al.  Strut coverage and vessel wall response to zotarolimus-eluting and bare-metal stents implanted in patients with ST-segment elevation myocardial infarction: the OCTAMI (Optical Coherence Tomography in Acute Myocardial Infarction) Study. , 2010, JACC. Cardiovascular interventions.

[13]  E. Halpern,et al.  Quantification of Macrophage Content in Atherosclerotic Plaques by Optical Coherence Tomography , 2003, Circulation.

[14]  Francesco Prati,et al.  Comparison of optical coherence tomography and intravascular ultrasound for the assessment of in-stent tissue coverage after stent implantation. , 2009, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[15]  Gary S. Mintz,et al.  Strut Coverage and Late Malapposition With Paclitaxel-Eluting Stents Compared With Bare Metal Stents in Acute Myocardial Infarction: Optical Coherence Tomography Substudy of the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial , 2011, Circulation.

[16]  Bernard Chevalier,et al.  Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes. , 2011, Journal of the American College of Cardiology.

[17]  M. Leon,et al.  Long-term follow-up after percutaneous transluminal coronary angioplasty was not performed based on intravascular ultrasound findings: importance of lumen dimensions. , 1999, Circulation.

[18]  E Regar,et al.  Optical coherence tomography assessment of the acute effects of stent implantation on the vessel wall: a systematic quantitative approach , 2009, Heart.

[19]  R. Charnigo,et al.  Long-term follow-up of drug-eluting stents placed in the setting of ST-segment elevation myocardial infarction. , 2011, JACC. Cardiovascular interventions.

[20]  L. Skovgaard,et al.  Strut apposition after coronary stent implantation visualised with optical coherence tomography. , 2010, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[21]  R. Virmani,et al.  Pathological Correlates of Late Drug-Eluting Stent Thrombosis: Strut Coverage as a Marker of Endothelialization , 2007, Circulation.

[22]  Eloisa Arbustini,et al.  Expert review document on methodology, terminology, and clinical applications of optical coherence tomography: physical principles, methodology of image acquisition, and clinical application for assessment of coronary arteries and atherosclerosis. , 2010, European heart journal.

[23]  N. Weissman,et al.  Intravascular ultrasound in the drug-eluting stent era. , 2006, Journal of the American College of Cardiology.

[24]  C. Macaya,et al.  Intravascular ultrasound findings during episodes of drug-eluting stent thrombosis. , 2007, Journal of the American College of Cardiology.

[25]  Patrick W. Serruys,et al.  Comparación cuantitativa ex vivo e in vivo de las dimensiones del lumen medidas por tomografía de coherencia óptica y ecografía intravascular en arterias coronarias humanas , 2009 .

[26]  N. Weissman,et al.  The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents. , 2008, European heart journal.

[27]  F. Prati,et al.  Detection of very early stent healing after primary angioplasty: an optical coherence tomographic observational study of chromium cobaltum and first-generation drug-eluting stents. The DETECTIVE Study , 2011, Heart.

[28]  A. Rollins,et al.  Intracoronary optical coherence tomography: a comprehensive review clinical and research applications. , 2009, JACC. Cardiovascular interventions.

[29]  P. Serruys,et al.  The fate of incomplete stent apposition with drug-eluting stents: an optical coherence tomography-based natural history study. , 2010, European heart journal.

[30]  P. Serruys,et al.  An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study. , 2010, European heart journal.

[31]  Michael Joner,et al.  Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. , 2006, Journal of the American College of Cardiology.

[32]  A. Lerman,et al.  Predictors of slow flow during primary percutaneous coronary intervention: an intravascular ultrasound-virtual histology study , 2008, Heart.

[33]  Bernard Chevalier,et al.  Evaluation of the Second Generation of a Bioresorbable Everolimus Drug-Eluting Vascular Scaffold for Treatment of De Novo Coronary Artery Stenosis: Six-Month Clinical and Imaging Outcomes , 2010, Circulation.

[34]  Hiroto Tsujioka,et al.  Advantage of next‐generation frequency‐domain optical coherence tomography compared with conventional time‐domain system in the assessment of coronary lesion , 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[35]  F Prati,et al.  Does optical coherence tomography identify arterial healing after stenting? An in vivo comparison with histology, in a rabbit carotid model , 2007, Heart.

[36]  K. Seung,et al.  Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound. , 2002, Journal of the American College of Cardiology.

[37]  Eiji Toyota,et al.  Assessment of coronary arterial thrombus by optical coherence tomography. , 2006, The American journal of cardiology.

[38]  L. Skovgaard,et al.  Strut apposition after coronary stent implantation visualised with optical coherence tomography. , 2010 .

[39]  Masanori Yamamoto,et al.  Evaluation by optical coherence tomography of neointimal coverage of sirolimus-eluting stent three months after implantation. , 2007, The American journal of cardiology.

[40]  Peter Barlis,et al.  Intravascular optical coherence tomography: optimisation of image acquisition and quantitative assessment of stent strut apposition. , 2007, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[41]  Francesco Prati,et al.  A multicentre evaluation of the safety of intracoronary optical coherence tomography. , 2009, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[42]  Brett E Bouma,et al.  Relationship Between a Systemic Inflammatory Marker, Plaque Inflammation, and Plaque Characteristics Determined by Intravascular Optical Coherence Tomography , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[43]  Akiko Maehara,et al.  A prospective natural-history study of coronary atherosclerosis. , 2011, The New England journal of medicine.

[44]  澤田 隆弘,et al.  Feasibility of combined use of intravascular ultrasound radiofrequency data analysis and optical coherence tomography for detecting thin-cap fibroatheroma , 2008 .

[45]  C. Tracy,et al.  American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. , 2001, Journal of the American College of Cardiology.

[46]  T. Akasaka,et al.  Lipid-rich plaque and myocardial perfusion after successful stenting in patients with non-ST-segment elevation acute coronary syndrome: an optical coherence tomography study. , 2009, European heart journal.

[47]  Patrick W Serruys,et al.  Incomplete stent apposition and delayed tissue coverage are more frequent in drug-eluting stents implanted during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction than in drug-eluting stents implanted for stable/unstable angina: insights from optical coherenc , 2009, JACC. Cardiovascular interventions.

[48]  J. Tanigawa,et al.  Heavily calcified coronary lesions preclude strut apposition despite high pressure balloon dilatation and rotational atherectomy: in-vivo demonstration with optical coherence tomography. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[49]  G. Stone,et al.  Long-term impact of routinely detected early and late incomplete stent apposition: an integrated intravascular ultrasound analysis of the TAXUS IV, V, and VI and TAXUS ATLAS workhorse, long lesion, and direct stent studies. , 2010, JACC. Cardiovascular interventions.

[50]  Brett E. Bouma,et al.  In Vivo Characterization of Coronary Atherosclerotic Plaque by Use of Optical Coherence Tomography , 2005, Circulation.

[51]  F. Alfonso Treatment of drug-eluting stent restenosis the new pilgrimage: quo vadis? , 2010, Journal of the American College of Cardiology.

[52]  Hiromasa Otake,et al.  Local determinants of thrombus formation following sirolimus-eluting stent implantation assessed by optical coherence tomography. , 2009, JACC. Cardiovascular interventions.

[53]  Paul G Yock,et al.  In vivo comparison between optical coherence tomography and intravascular ultrasound for detecting small degrees of in-stent neointima after stent implantation. , 2008, JACC. Cardiovascular interventions.

[54]  C. Buller,et al.  Intracoronary ultrasound predictors of adverse outcomes after coronary artery interventions. , 1992, Journal of the American College of Cardiology.

[55]  Evelyn Regar,et al.  Fully automatic three‐dimensional quantitative analysis of intracoronary optical coherence tomography , 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[56]  P. Serruys,et al.  Quantitative ex vivo and in vivo comparison of lumen dimensions measured by optical coherence tomography and intravascular ultrasound in human coronary arteries. , 2009, Revista espanola de cardiologia.

[57]  P. Serruys,et al.  Quantitative multi-modality imaging analysis of a fully bioresorbable stent: a head-to-head comparison between QCA, IVUS and OCT , 2011, The International Journal of Cardiovascular Imaging.

[58]  Patrick W Serruys,et al.  A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods , 2009, The Lancet.

[59]  Takashi Akasaka,et al.  Comparison of vascular response after sirolimus-eluting stent implantation between patients with unstable and stable angina pectoris: a serial optical coherence tomography study. , 2008, JACC. Cardiovascular imaging.

[60]  G. Stone,et al.  Intravascular Ultrasound Findings of Early Stent Thrombosis After Primary Percutaneous Intervention in Acute Myocardial Infarction: A Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Substudy , 2011, Circulation. Cardiovascular interventions.

[61]  Eloisa Arbustini,et al.  Sources of error and interpretation of plaque morphology by optical coherence tomography. , 2006, The American journal of cardiology.

[62]  A. Colombo,et al.  Does IVUS guidance of coronary interventions affect outcome? a prime example of the failure of randomized clinical trials , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.